05/04/2023 - Accelerate Diagnostics Inc.: Initial Statement of Beneficial Ownership - Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number:3235-0104Expires:January 31, 2005Estimated average burden hours per response...0.5

1. Name and Address of Reporting Person * Patience David 2. Date of Event Requiring Statement (Month/Day/Year) 2023-04-01 3. Issuer Name and Ticker or Trading Symbol Accelerate Diagnostics, Inc [AXDX] (Last) (First) (Middle) C/O ACCELERATE DIAGNOSTICS, INC. , 3950 S. COUNTRY CLUB ROAD, SUITE 470 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) Chief Financial Officer / 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) TUCSON AZ 85714 6. Individual or Join/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security 2. Amount of Securities Beneficially Owned 3. Ownership Form: Direct (D) or Indirect (I) 4. Nature of Indirect Beneficial Ownership

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivate Security	2. Date Exercisable and Expiration Date	3. Title and Amount of Securities Underlying Derivative Security	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)	6. Nature of Indirect Beneficial Ownership
Date Exercisable	Expriation Date	Title	Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
Director	10% Owner	Officer	Other
Patience David C/O ACCELERATE DIAGNOSTICS, INC. 3950 S. COUNTRY CLUB ROAD, SUITE 470 TUCSON, AZ85714			Chief Financial Officer

Signatures

/s/ David Patience	2023-04-04
**Signature of Reporting Person	Date

Explanation of Responses:

(*)	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
(**)	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The reporting person received an aggregate of 39,707 restricted stock units on March 13, 2021, which will vest in equal monthly amounts over 22 months. As of the date of this Form 3, 9,927 restricted stock units have vested leaving the remaining 29,780 restricted stock units to vest over the remain vesting period. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
(2)	Not applicable.
(3)	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
(4)	The reporting person received 25,000 restricted stock units on February 26, 2022, of which 40% vests on February 26, 2024 and the remaining 60% will vest on February 26, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
(5)	On September 8, 2022, the stock option became fully vested and exercisable.
(6)	On March 7, 2018, the stock option became fully vested and exercisable.
(7)	On September 30, 2019, the stock option became fully vested and exercisable.
(8)	On January 1, 2023, the stock option became fully vested and exercisable.
(9)	On September 30, 2020, the stock option became fully vested and exercisable.
(10)	The reporting person received 10,000 stock options on March 24, 2020, which will vest in equal annual amounts every year over five years. As of the date of this Form 3, 6,000 stock options have vested and the remaining 4,000 stock options are set to vest over the remaining vesting period.
(11)	On March 24, 2020, the stock option became fully vested and exercisable.
(12)	On April 16, 2022, the stock option became fully vested and exercisable.
(13)	The reporting person received 40,000 stock options on March 7, 2022, of which 40% vests on March 7, 2024 and the remaining 60% will vest on March 7, 2025.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.